BackAspire Biopharma Holdings Overview

Aspire Biopharma Holdings Total Liabilities

Aspire Biopharma Holdings's total liabilities is $3.2M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$3.25M
↓ 63.57% YoYΔ $-5.67M vs prior year quarter

Peer average

Loading

Aspire Biopharma Holdings Total Liabilities History

Loading

Aspire Biopharma Holdings vs. peers: Total Liabilities Comparison

Loading

Aspire Biopharma Holdings Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Aspire Biopharma Holdings (ASBP) FAQ

Aspire Biopharma Holdings (ASBP) currently reports a total liabilities of $3.2M as of March 2026. That compares with $8.9M in the prior-year period — down 63.6% year over year. Use the charts on this page to explore Aspire Biopharma Holdings's total liabilities history and peer comparisons.

Aspire Biopharma Holdings's total liabilities decreased from $8.9M to $3.2M — a 63.6% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aspire Biopharma Holdings reported $3.2M in total liabilities as of March 2026. That compares with $8.9M in the prior-year period — down 63.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $3.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aspire Biopharma Holdings, and consider following ASBP for alerts when major investors trade the stock.